ETF PRO AIOctober 4, 2026
PPH VanEck Pharmaceutical ETF
Fund tearsheet · data as of the latest session · October 4, 2026
ONE YEAR OF DAILY CLOSES
0.36%expense ratio
$1Bfund assets
+4.7%return, YTD
+14.9%return, 1 year
+$44Mnet flow, 1 month
+$325Mnet flow, 1 year
17.7%realized volatility, 1y
-11.5%worst drawdown, 1y
Top ten holdings
| 1 | LLY ELI LILLY | 20.80% |
| 2 | MRK MERCK & CO | 13.33% |
| 3 | NVO NOVO NORDISK A S | 5.59% |
| 4 | PFE PFIZER | 5.15% |
| 5 | BMY BRISTOL MYERS SQUIBB | 4.80% |
| 6 | TEVA TEVA PHARMACEUTICAL | 4.77% |
| 7 | MCK MCKESSON | 4.61% |
| 8 | GSK GSK | 4.44% |
| 9 | COR CENCORA INC | 4.38% |
| 10 | ABBV ABBVIE | 3.64% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS